Clinical Trial: Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865676) titled 'Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia' on Oct. 03.

Brief Summary: 1. To evaluate the safety and tolerability of CG-BM1 for the treatment of patients with Sarcopenia.

2. To observe the preliminary effectiveness of CG-BM1 in treating Sarcopenia patients.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Sarcopenia

Intervention: BIOLOGICAL: CG-BM1

Intravenous infusion, once monthly for a total of 2 administrations.

Recruitment Status: RECRUITING

Sponsor: GuangZhou Cellgenes Biotechnology Co., Ltd.

Disclaimer: Curated by HT Syndicatio...